Zenas BioPharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Zenas BioPharma, Inc. (ZBIO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.16 million as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-16
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.16M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $457.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $455.00K.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $453.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $1.16M 10-K · filed 2026-03-16 |
| 2025-09-30 | $457.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $455.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $453.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $896.00K 10-K · filed 2025-03-11 |
| 2024-09-30 | $439.00M 10-Q · filed 2024-11-12 |